Takip et
Lucila Isabel Castro Pastrana
Lucila Isabel Castro Pastrana
Universidad de las Américas Puebla
udlap.mx üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children
BR Del Pozzo-Magana, A Lazo-Langner, B Carleton, LI Castro-Pastrana, ...
J Popul Ther Clin Pharmacol 18 (1), 121-33, 2011
1762011
HLA‐A* 31: 01 and HLA‐B* 15: 02 as genetic markers for carbamazepine hypersensitivity in children
U Amstutz, CJD Ross, LI Castro‐Pastrana, MJ Rieder, NH Shear, ...
Clinical Pharmacology & Therapeutics 94 (1), 142-149, 2013
1432013
Ecofarmacovigilancia en México: perspectivas para su implementación
LI Castro-Pastrana, MI Baños-Medina, MA López-Luna, BL Torres-García
Revista Mexicana de Ciencias Farmacéuticas 46 (3), 16-40, 2015
772015
Pharmacogenomics of serious adverse drug reactions in pediatric oncology
CJ Ross, H Visscher, SR Rassekh, LI Castro-Pastrana, E Shereck, ...
J Popul Ther Clin Pharmacol 18 (1), 134-51, 2011
542011
Reacciones adversas a medicamentos relacionadas con ingresos y estancias hospitalarias: revisión sistemática de 2000-2011
SG Salas Rojas, ME Pérez Morales, SG Meléndez López, ...
Revista mexicana de ciencias farmacéuticas 43 (3), 19-35, 2012
492012
Prescription errors in a primary care university unit: urgency of pharmaceutical care in Mexico
M Zavaleta-Bustos, LI Castro-Pastrana, I Reyes-Hernández, ...
Revista Brasileira de Ciências Farmacêuticas 44, 115-125, 2008
462008
Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge.
LI Castro-Pastrana, BC Carleton
Journal of Population Therapeutics and Clinical Pharmacology= Journal de la …, 2011
382011
Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS)
LI Castro-Pastrana, R Ghannadan, MJ Rieder, E Dahlke, M Hayden, ...
J Popul Ther Clin Pharmacol 18 (1), e106-e120, 2011
342011
Caracterización de la práctica de la atención farmacéutica en instituciones hospitalarias de Santiago de Cuba
I Reyes Hernández, IB Bermúdez Camps, LI Castro Pastrana, MA Brice, ...
Revista Cubana de Farmacia 47 (2), 225-238, 2013
282013
Effects of effluent from a hospital in Mexico on the embryonic development of zebrafish, Danio rerio
P Tenorio-Chávez, M Cerro-López, LI Castro-Pastrana, ...
Science of The Total Environment 727, 138716, 2020
272020
Intravenous administration errors intercepted by smart infusion technology in an adult intensive care unit
R Ibarra-Pérez, F Puértolas-Balint, E Lozano-Cruz, SE Zamora-Gómez, ...
Journal of Patient Safety 17 (6), 430-436, 2021
232021
Análisis de fármacos en aguas residuales de tres hospitales de la ciudad de Puebla, México
SSMD Castro-Pastrana LI, Cerro-López M, Toledo-Wall ML, Gómez-Oliván LM
Ingeniería del agua 25 (1), 59-73, 2021
18*2021
Prevalencia de interacciones farmacológicas en pacientes hospitalizados en el servicio de medicina interna de un hospital general de México
E Palacios-Rosas, MP León-Domínguez, LI Castro-Pastrana
Anales de la Facultad de Medicina 82 (3), 206-210, 2021
172021
Ecofarmacovigilancia.
MA De Loera-González, SH Sánchez-Rodríguez, LI Castro-Pastrana, ...
Revista CENIC: Ciencias Biológicas 47 (1), 12-17, 2016
17*2016
Gestión de la calidad en Unidades de Farmacovigilancia Hospitalaria: Propuesta de indicadores de la red ASEGUREMHOS
LI Castro-Pastrana, P Pedraza-Montero, R Ortiz-Islas, ...
Revista mexicana de ciencias farmacéuticas 45 (1), 57-77, 2014
142014
Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study
LC Lopes, M Salas, CGS Osorio‐de‐Castro, LF Leal, SV Doubova, ...
Pharmacoepidemiology and drug safety 31 (3), 343-352, 2022
122022
Pharmacogenomic investigation of adverse drug reactions (ADRs): the ADR prioritization tool, APT
K Shaw, U Amstutz, L Castro-Pastrana, TT Loo, CJ Ross, S Ito, MJ Reider, ...
J. Popul. Ther. Clin. Pharmacol 20 (2), e110-e127, 2013
122013
Worldwide occurrence, detection, and fate of nonsteroidal anti-inflammatory drugs in water
LI Castro-Pastrana, E Palacios-Rosas, ML Toledo-Wall, M Cerro-López
Non-Steroidal Anti-Inflammatory Drugs in Water: Emerging Contaminants and …, 2020
112020
Mesostructured lead dioxide grown on Titania nanotubes for diclofenac water removal through eletrocatalytic and photoelectrocatalytic processes
MHCA Cerro-López M, Castro-Pastrana LI, Campos-Delgado J, Rubio-Rosas E ...
Environmental research 231 (3), 116094, 2023
82023
Pharmaceuticals reaching the environment: concepts, evidence, and concerns
E Palacios-Rosas, LI Castro-Pastrana
Ecopharmacovigilance: Multidisciplinary Approaches to Environmental Safety …, 2017
72017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20